BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-09-22 |
|---|---|---|---|---|
| 2023 | $86.25 | $86.1 | $86.36 | -0.3% |
| 2024 | $89.44 | $86.94 | $93.07 | 3.39% |
| 2025 | $117.29 | $94.35 | $147.44 | 35.58% |
| 2026 | $166.53 | $151.36 | $178.65 | 92.5% |
| 2027 | $183.9 | $180.01 | $185.66 | 112.58% |
| 2028 | $172.37 | $151.16 | $184.24 | 99.25% |
| 2029 | $107.46 | $81.91 | $143.24 | 24.22% |
| 2030 | $77.59 | $72.88 | $80.19 | -10.31% |
| 2031 | $67.04 | $65.17 | $68.82 | -22.5% |
| 2032 | $66.27 | $63.65 | $71.08 | -23.4% |
| 2033 | $77.9 | $72.92 | $81.84 | -9.95% |
The 27 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$112.56 with a high forecast of $185.0 and a low forecast of $69.0.
The average BioMarin Pharmaceutical stock forecast represents a 30.11%
increase from the last price of $86.5100021362305.
From AI system, total return is 2366.52% from 4098 forecasts.
For BioMarin Pharmaceutical stock forecast for 2023, 3 predictions are offered for each month of 2023 with average BioMarin Pharmaceutical stock
forecast of $86.25, a high forecast of $86.36, and a low forecast of $86.1.
The average BioMarin Pharmaceutical stock forecast 2023 represents a -0.3%
decrease from the last price of $86.5100021362305.
For BioMarin Pharmaceutical stock forecast for 2024, 12 predictions are offered for each month of 2024 with average BioMarin Pharmaceutical stock
forecast of $89.44, a high forecast of $93.07, and a low forecast of $86.94.
The average BioMarin Pharmaceutical stock forecast 2024 represents a 3.39%
increase from the last price of $86.5100021362305.
For BioMarin Pharmaceutical stock forecast for 2026, 12 predictions are offered for each month of 2026 with average BioMarin Pharmaceutical stock
forecast of $166.53, a high forecast of $178.65, and a low forecast of $151.36.
The average BioMarin Pharmaceutical stock forecast 2026 represents a 92.5%
increase from the last price of $86.5100021362305.
For BioMarin Pharmaceutical stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average BioMarin Pharmaceutical stock
forecast of $172.37, a high forecast of $184.24, and a low forecast of $151.16.
The average BioMarin Pharmaceutical stock forecast 2028 represents a 99.25%
increase from the last price of $86.5100021362305.
For BioMarin Pharmaceutical stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BioMarin Pharmaceutical stock
forecast of $67.04, a high forecast of $68.82, and a low forecast of $65.17.
The average BioMarin Pharmaceutical stock forecast 2031 represents a -22.5%
decrease from the last price of $86.5100021362305.
For BioMarin Pharmaceutical stock forecast for 2033 (10 year), 9 predictions are offered for each month of 2033 with average BioMarin Pharmaceutical stock
forecast of $77.9, a high forecast of $81.84, and a low forecast of $72.92.
The average BioMarin Pharmaceutical stock forecast 2033 represents a -9.95%
decrease from the last price of $86.5100021362305.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $112.56, and this show a -2.31% decrease in average from the prior price target of the each prediction. Also, this average forecast of $112.56 represents a 1.2% increase from the past average forecast of $111.22, 6 months ago from 23 wall street analysts.
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-09-26 | $81.35 | -5.96% |
| 2023-09-27 | $80.67 | -0.85% |
| 2023-09-28 | $76.87 | -4.71% |
| 2023-09-29 | $73.58 | -4.28% |
| 2023-10-02 | $73.52 | -0.08% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Oct. is $86.31 , for 2024 Sep. is $90.95 , for 2027 Sep. is $185.66 , for 2028 Sep. is $167.75 , for 2032 Sep. is $67.02 , and for 2033 Sep. is $81.84.
BMRN : BioMarin Pharmaceutical stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Oct. | $86.31 | -0.24% |
| 2023 Nov. | $86.10 | -0.24% |
| 2023 Dec. | $86.36 | 0.30% |
BMRN : BioMarin Pharmaceutical stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $86.94 | 0.68% |
| 2024 Feb. | $87.30 | 0.41% |
| 2024 Mar. | $87.63 | 0.38% |
| 2024 Apr. | $88.07 | 0.49% |
| 2024 May. | $88.41 | 0.39% |
| 2024 Jun. | $88.51 | 0.12% |
| 2024 Jul. | $88.71 | 0.22% |
| 2024 Aug. | $89.70 | 1.12% |
| 2024 Sep. | $90.95 | 1.40% |
| 2024 Oct. | $91.69 | 0.81% |
| 2024 Nov. | $92.30 | 0.67% |
| 2024 Dec. | $93.07 | 0.82% |
BMRN : BioMarin Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $94.35 | 1.39% |
| 2025 Feb. | $96.20 | 1.95% |
| 2025 Mar. | $98.77 | 2.68% |
| 2025 Apr. | $102.19 | 3.46% |
| 2025 May. | $106.40 | 4.11% |
| 2025 Jun. | $111.42 | 4.73% |
| 2025 Jul. | $117.26 | 5.24% |
| 2025 Aug. | $123.70 | 5.49% |
| 2025 Sep. | $130.43 | 5.44% |
| 2025 Oct. | $136.76 | 4.85% |
| 2025 Nov. | $142.57 | 4.24% |
| 2025 Dec. | $147.44 | 3.42% |
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $151.36 | 2.66% |
| 2026 Feb. | $154.41 | 2.01% |
| 2026 Mar. | $157.19 | 1.80% |
| 2026 Apr. | $160.60 | 2.17% |
| 2026 May. | $163.71 | 1.94% |
| 2026 Jun. | $166.41 | 1.65% |
| 2026 Jul. | $168.90 | 1.50% |
| 2026 Aug. | $171.24 | 1.38% |
| 2026 Sep. | $173.44 | 1.28% |
| 2026 Oct. | $175.33 | 1.09% |
| 2026 Nov. | $177.09 | 1.01% |
| 2026 Dec. | $178.65 | 0.88% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $180.01 | 0.76% |
| 2027 Feb. | $181.18 | 0.65% |
| 2027 Mar. | $182.19 | 0.56% |
| 2027 Apr. | $183.10 | 0.50% |
| 2027 May. | $183.93 | 0.45% |
| 2027 Jun. | $184.68 | 0.41% |
| 2027 Jul. | $185.27 | 0.32% |
| 2027 Aug. | $185.61 | 0.18% |
| 2027 Sep. | $185.66 | 0.03% |
| 2027 Oct. | $185.47 | -0.11% |
| 2027 Nov. | $185.10 | -0.20% |
| 2027 Dec. | $184.66 | -0.23% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $184.24 | -0.23% |
| 2028 Feb. | $183.58 | -0.36% |
| 2028 Mar. | $182.18 | -0.76% |
| 2028 Apr. | $180.11 | -1.14% |
| 2028 May. | $177.88 | -1.23% |
| 2028 Jun. | $175.66 | -1.25% |
| 2028 Jul. | $173.34 | -1.32% |
| 2028 Aug. | $170.81 | -1.46% |
| 2028 Sep. | $167.75 | -1.79% |
| 2028 Oct. | $163.63 | -2.46% |
| 2028 Nov. | $158.10 | -3.38% |
| 2028 Dec. | $151.16 | -4.39% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $143.24 | -5.24% |
| 2029 Feb. | $135.54 | -5.37% |
| 2029 Mar. | $128.25 | -5.38% |
| 2029 Apr. | $121.07 | -5.60% |
| 2029 May. | $114.16 | -5.70% |
| 2029 Jun. | $107.59 | -5.76% |
| 2029 Jul. | $101.16 | -5.98% |
| 2029 Aug. | $95.30 | -5.79% |
| 2029 Sep. | $90.49 | -5.05% |
| 2029 Oct. | $86.77 | -4.11% |
| 2029 Nov. | $84.04 | -3.15% |
| 2029 Dec. | $81.91 | -2.53% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $80.19 | -2.10% |
| 2030 Feb. | $78.87 | -1.65% |
| 2030 Mar. | $77.84 | -1.31% |
| 2030 Apr. | $77.36 | -0.62% |
| 2030 May. | $77.52 | 0.21% |
| 2030 Jun. | $77.77 | 0.32% |
| 2030 Jul. | $77.59 | -0.23% |
| 2030 Aug. | $76.69 | -1.15% |
| 2030 Sep. | $77.41 | 0.94% |
| 2030 Oct. | $79.61 | 2.84% |
| 2030 Nov. | $77.35 | -2.84% |
| 2030 Dec. | $72.88 | -5.78% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $68.82 | -5.57% |
| 2031 Feb. | $66.20 | -3.82% |
| 2031 Mar. | $65.17 | -1.54% |
| 2031 Apr. | $65.72 | 0.83% |
| 2031 May. | $66.71 | 1.50% |
| 2031 Jun. | $67.36 | 0.98% |
| 2031 Jul. | $67.59 | 0.35% |
| 2031 Aug. | $67.56 | -0.05% |
| 2031 Sep. | $67.30 | -0.38% |
| 2031 Oct. | $67.16 | -0.22% |
| 2031 Nov. | $67.43 | 0.41% |
| 2031 Dec. | $67.49 | 0.09% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $66.78 | -1.05% |
| 2032 Feb. | $65.48 | -1.95% |
| 2032 Mar. | $64.25 | -1.87% |
| 2032 Apr. | $63.65 | -0.94% |
| 2032 May. | $63.77 | 0.20% |
| 2032 Jun. | $64.37 | 0.94% |
| 2032 Jul. | $65.18 | 1.25% |
| 2032 Aug. | $66.06 | 1.36% |
| 2032 Sep. | $67.02 | 1.45% |
| 2032 Oct. | $68.12 | 1.63% |
| 2032 Nov. | $69.44 | 1.95% |
| 2032 Dec. | $71.08 | 2.36% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $72.92 | 2.59% |
| 2033 Feb. | $74.70 | 2.44% |
| 2033 Mar. | $76.21 | 2.02% |
| 2033 Apr. | $77.38 | 1.53% |
| 2033 May. | $78.27 | 1.15% |
| 2033 Jun. | $79.07 | 1.02% |
| 2033 Jul. | $79.91 | 1.07% |
| 2033 Aug. | $80.82 | 1.13% |
| 2033 Sep. | $81.84 | 1.26% |
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2023 Oct. is $86.3059655284099 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2024 Sep. is $90.9539633902361 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2027 Sep. is $185.662213578107 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2028 Sep. is $167.753603545193 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2032 Sep. is $67.0230732248208 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2033 Sep. is $81.8352960096228
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go UP . Therefore, Tudal would say that BioMarin Pharmaceutical (BMRN) stock is NOT overvalued.
Will BioMarin Pharmaceutical stock price go up?
Yes. The BioMarin Pharmaceutical stock price forecast for 2024 Sep. is $90.9539633902361
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2023-09-22 is $86.5100021362305 and forecast for 2024 Sep. is $90.95, BioMarin Pharmaceutical stock is a good 1 year investment.